Altan Pharma Submits New Drug Application for Acetaminophen Solution for Infusion for Treatment of Pain and Reduction of Fever

Dublin, February 7, 2019, Altan Pharma Limited (“Altan”), an Irish specialty pharmaceutical company, today announces that it has submitted a New Drug Application (NDA) for its formulation of acetaminophen solution for infusion to the United States Food and Drug Administration (FDA) and that it has been accepted for review. The NDA was submitted pursuant to section 505(b)(2) of the Food, Drug and Cosmetic Act.